These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23485336)

  • 21. Measuring the binding stoichiometry of HIV-1 Gag to very-low-density oligonucleotide surfaces using surface plasmon resonance spectroscopy.
    Stephen AG; Datta SA; Worthy KM; Bindu L; Fivash MJ; Turner KB; Fabris D; Rein A; Fisher RJ
    J Biomol Tech; 2007 Sep; 18(4):259-66. PubMed ID: 17916799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure of the antiviral assembly inhibitor CAP-1 complex with the HIV-1 CA protein.
    Kelly BN; Kyere S; Kinde I; Tang C; Howard BR; Robinson H; Sundquist WI; Summers MF; Hill CP
    J Mol Biol; 2007 Oct; 373(2):355-66. PubMed ID: 17826792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The HIV-1 nucleocapsid protein recruits negatively charged lipids to ensure its optimal binding to lipid membranes.
    Kempf N; Postupalenko V; Bora S; Didier P; Arntz Y; de Rocquigny H; Mély Y
    J Virol; 2015 Feb; 89(3):1756-67. PubMed ID: 25410868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of HIV-1 Nucleocapsid Protein Inhibition by Lysyl-Peptidyl-Anthraquinone Conjugates.
    Sosic A; Sinigaglia L; Cappellini M; Carli I; Parolin C; Zagotto G; Sabatino G; Rovero P; Fabris D; Gatto B
    Bioconjug Chem; 2016 Jan; 27(1):247-56. PubMed ID: 26666402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methods for the analysis of HIV-1 nucleocapsid protein interactions with oligonucleotides.
    Stephen AG; Fisher RJ
    Methods Mol Biol; 2009; 485():209-21. PubMed ID: 19020828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selection and stabilization of the RNA aptamers against the human immunodeficiency virus type-1 nucleocapsid protein.
    Kim SJ; Kim MY; Lee JH; You JC; Jeong S
    Biochem Biophys Res Commun; 2002 Mar; 291(4):925-31. PubMed ID: 11866454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of HIV-1 nucleocapsid protein: nucleic acid antagonists with cellular anti-HIV activity.
    Stephen AG; Worthy KM; Towler E; Mikovits JA; Sei S; Roberts P; Yang QE; Akee RK; Klausmeyer P; McCloud TG; Henderson L; Rein A; Covell DG; Currens M; Shoemaker RH; Fisher RJ
    Biochem Biophys Res Commun; 2002 Sep; 296(5):1228-37. PubMed ID: 12207905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New therapeutic approaches targeted at the late stages of the HIV-1 replication cycle.
    Jiang Y; Liu X; De Clercq E
    Curr Med Chem; 2011; 18(1):16-28. PubMed ID: 21110817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A tryptophan-rich hexapeptide inhibits nucleic acid destabilization chaperoned by the HIV-1 nucleocapsid protein.
    Raja C; Ferner J; Dietrich U; Avilov S; Ficheux D; Darlix JL; de Rocquigny H; Schwalbe H; Mély Y
    Biochemistry; 2006 Aug; 45(30):9254-65. PubMed ID: 16866372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanistic differences between HIV-1 and SIV nucleocapsid proteins and cross-species HIV-1 genomic RNA recognition.
    Post K; Olson ED; Naufer MN; Gorelick RJ; Rouzina I; Williams MC; Musier-Forsyth K; Levin JG
    Retrovirology; 2016 Dec; 13(1):89. PubMed ID: 28034301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Site-specific characterization of HIV-1 nucleocapsid protein binding to oligonucleotides with two binding sites.
    Avilov SV; Godet J; Piémont E; Mély Y
    Biochemistry; 2009 Mar; 48(11):2422-30. PubMed ID: 19186983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nucleic acid binding and chaperone properties of HIV-1 Gag and nucleocapsid proteins.
    Cruceanu M; Urbaneja MA; Hixson CV; Johnson DG; Datta SA; Fivash MJ; Stephen AG; Fisher RJ; Gorelick RJ; Casas-Finet JR; Rein A; Rouzina I; Williams MC
    Nucleic Acids Res; 2006; 34(2):593-605. PubMed ID: 16449201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitory Effect of Lithospermic Acid on the HIV-1 Nucleocapsid Protein.
    Mori M; Ciaco S; Mély Y; Karioti A
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33233563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of small molecule inhibitors of the HIV-1 nucleocapsid-stem-loop 3 RNA complex.
    Warui DM; Baranger AM
    J Med Chem; 2012 May; 55(9):4132-41. PubMed ID: 22480197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initiation of HIV-1 reverse transcription and functional role of nucleocapsid-mediated tRNA/viral genome interactions.
    Sleiman D; Goldschmidt V; Barraud P; Marquet R; Paillart JC; Tisné C
    Virus Res; 2012 Nov; 169(2):324-39. PubMed ID: 22721779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The RNA recognition mechanism of human immunodeficiency virus (HIV) type 2 NCp8 is different from that of HIV-1 NCp7.
    Matsui T; Tanaka T; Endoh H; Sato K; Tanaka H; Miyauchi E; Kawashima Y; Nagai-Makabe M; Komatsu H; Kohno T; Maeda T; Kodera Y
    Biochemistry; 2009 May; 48(20):4314-23. PubMed ID: 19334676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural insights into the cTAR DNA recognition by the HIV-1 nucleocapsid protein: role of sugar deoxyriboses in the binding polarity of NC.
    Bazzi A; Zargarian L; Chaminade F; Boudier C; De Rocquigny H; René B; Mély Y; Fossé P; Mauffret O
    Nucleic Acids Res; 2011 May; 39(9):3903-16. PubMed ID: 21227929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complex interactions of HIV-1 nucleocapsid protein with oligonucleotides.
    Fisher RJ; Fivash MJ; Stephen AG; Hagan NA; Shenoy SR; Medaglia MV; Smith LR; Worthy KM; Simpson JT; Shoemaker R; McNitt KL; Johnson DG; Hixson CV; Gorelick RJ; Fabris D; Henderson LE; Rein A
    Nucleic Acids Res; 2006; 34(2):472-84. PubMed ID: 16434700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of HIV budding by a genetically selected cyclic peptide targeting the Gag-TSG101 interaction.
    Tavassoli A; Lu Q; Gam J; Pan H; Benkovic SJ; Cohen SN
    ACS Chem Biol; 2008 Dec; 3(12):757-64. PubMed ID: 19053244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV-1 nucleocapsid protein as a nucleic acid chaperone: spectroscopic study of its helix-destabilizing properties, structural binding specificity, and annealing activity.
    Urbaneja MA; Wu M; Casas-Finet JR; Karpel RL
    J Mol Biol; 2002 May; 318(3):749-64. PubMed ID: 12054820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.